L
Lifebit
Empowers therapeutic leaders and pioneers in precision medicine on how to access and analyse siloed biomedical data
About Lifebit
Lifebit.ai is a cutting-edge startup that operates in the biomedical data sector. The company's primary focus is to make biomedical data easily accessible and securely usable, which is crucial in accelerating breakthroughs and curing diseases. Lifebit.ai serves a broad range of clients, including researchers in rare disease and cancer research, and organizations looking to harness the power of biomedical data.
Read full description
The company's business model revolves around its Trusted Research Environment, a next-generation technology that allows clients to connect to the world's otherwise locked-up data to obtain novel therapeutic insights. This technology can accelerate target discovery and validation to as little as a few months, enabling life-saving drugs to be brought to market faster.
Lifebit.ai also offers end-to-end solutions, guiding organizations through the entire process of clinico-genomic data harmonization and setting up the infrastructure to enable research and clinical insights. The company's services also include aligning clients' data landscape and research needs, shaping their data acquisition strategy, and realizing the potential of their data.
The company's revenue is likely generated through a combination of service fees for its platform and consulting services. Lifebit.ai also partners with other tech giants like AWS to enhance its research capabilities.
In terms of security, Lifebit.ai protects sensitive health data with best-in-class security procedures. The company also offers a federated architecture and cloud specialists, allowing clients to build simple, yet powerful, workflows in the language of their choice.
At a glance
- Status
- Operational
- Founded
- 2017
- Headquarters
- London, United Kingdom
- Employees
- 68
- Open positions
- 3
- Dealroom signal
- 65.1/100
- Industry
- Health
- Sub-industry
- BioTechnology
- Sector
- Biotech & Life Sciences, Open Source, Analytics, Data Analytics, Biotechnology, uk rio, Drug Development, DNA, Genetics and genomics, Core AI, Precision Medicine, Disease
- Business model
- SaaS
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES BOther financing | Sep 2021 | $60M | $240M | Eurazeo · Pentech Ventures · Beacon Capital · Tiger Global | — |
| SERIES AOther financing | Apr 2020 | $7.5M | $30M | Eurazeo · Connect Ventures (Europe) · Pentech Ventures · Beacon Capital | — |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for Lifebit is 25K monthly website visits, up 25% over the last three months. Lifebit's team declined 8.1% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed4 investors entered at this stage
Connect Ventures (Europe)
Pentech Ventures
Beacon Capital
Tiny Capital
Series A2 investors entered at this stage
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Lifebit on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Lifebit’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.